Evidence map›Paper›PMID 36333098›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2022

CSF1R-Mediated Myeloid Cell Depletion Prolongs Lifespan But Aggravates Distinct Motor Symptoms in a Model of Multiple System Atrophy.

Kristina Battis, Jazmin B Florio, Michael Mante, Addison Lana, Isabel Naumann, Carina Gauer, Vera Lambrecht, Simon Julian Müller, Isidoro Cobo, Bethany Fixsen and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Inflammation in multiple system atrophy.Frontiers in immunology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 2 countries.

Kristina BattisDepartment of Molecular Neurology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, 91054, Germany.
Jazmin B FlorioDepartment of Neurosciences, University of California-San Diego, La Jolla, California 92093.
Michael ManteDepartment of Neurosciences, University of California-San Diego, La Jolla, California 92093.
Addison LanaDepartment of Cellular and Molecular Medicine, University of California-San Diego, La Jolla, California 92093.
Isabel NaumannDepartment of Molecular Neurology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, 91054, Germany.
Carina GauerDepartment of Molecular Neurology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, 91054, Germany.
Vera LambrechtDepartment of Molecular Neurology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, 91054, Germany.
Simon Julian MüllerDepartment of Molecular Neurology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, 91054, Germany.
Isidoro CoboDepartment of Cellular and Molecular Medicine, University of California-San Diego, La Jolla, California 92093.
Bethany FixsenDepartment of Cellular and Molecular Medicine, University of California-San Diego, La Jolla, California 92093.
Ha Yeon KimDepartment of Neurosciences, University of California-San Diego, La Jolla, California 92093.
Eliezer MasliahDivision of Neuroscience, National Institute on Aging, National Institutes of Health, Bethesda, Maryland 20892.
Christopher K GlassDepartment of Cellular and Molecular Medicine, University of California-San Diego, La Jolla, California 92093.
Johannes C M SchlachetzkiDepartment of Cellular and Molecular Medicine, University of California-San Diego, La Jolla, California 92093.
Robert A RissmanDepartment of Neurosciences, University of California-San Diego, La Jolla, California 92093.
Jürgen WinklerDepartment of Molecular Neurology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, 91054, Germany.
Alana HoffmannDepartment of Molecular Neurology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, 91054, Germany Alana.hoffmann@uk-erlangen.de.ORCID https://orcid.org/0000-0002-5476-1038
University of California San Diego · USFriedrich-Alexander-Universität Erlangen-Nürnberg · DENational Institutes of Health · US

Funding

The Alzheimer's Clinical Trial Consortium - Down Syndrome Network (ACTC- DSN)U24AG057437 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Paul S. Aisen, RONALD C PETERSEN · 2018 to 2026
$198.4M
TRIAL OF VALPROATE TO ATTENUATE THE PROGRESSION OF ADU01AG010483 · NIA · UNIVERSITY OF ROCHESTER · PI AISEN, PAUL S. · 1991 to 2012
$116.2M
UCSD Shiley-Marcos Alzheimer's Disease Research Center P30P30AG062429 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Mark W Bondi · 2019 to 2026
$34.9M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007198 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHI, NEIL C, INSEL, PAUL A · 1985 to 2024
$29.3M
USCADRC Diversity Supplement PachicanoP30AG066530 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HELENA Chang CHUI, ARTHUR W TOGA · 2020 to 2026
$27.8M
B-Synuclein as a Treatment for Lewy Body DiseaseR01AG018440 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI RISSMAN, ROBERT · 2001 to 2021
$5.2M
Proinflammatory Endophenotype to predict NSAID treatment response Alzheimer's trialsR01AG051848 · NIA · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI LYKETSOS, CONSTANTINE G, O'BRYANT, SID E · 2016 to 2020
$3.7M
A Blood Test for Screening Into Alzheimer's Prevention TrialsR01AG058252 · NIA · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI O'BRYANT, SID E, RISSMAN, ROBERT · 2017 to 2021
$3.2M
Precision Medicine for Inflammatory Treatment for Alzheimer's Disease in Down SyndromeRF1AG073979 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI RAFII, MICHAEL S, RISSMAN, ROBERT · 2021 to 2022
$2.6M
Novel Systemic Delivery of Peptide-Mediated Anti-Sense Oligonucleotides for Dementia with Lewy BodiesRF1AG072053 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI RISSMAN, ROBERT · 2021 to 2021
$1.8M
Precision Medicine for Inflammatory Treatment for Alzheimer's Disease in Down SyndromeR01AG073979 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI RAFII, MICHAEL S, RISSMAN, ROBERT · 2024 to 2025
$1.2M
NIA NIH HHS P30 AG062429NIA NIH HHS P30 AG066530NIA NIH HHS R01 AG018440NIA NIH HHS R01 AG051848NIA NIH HHS R01 AG058252NIA NIH HHS R01 AG073979NIA NIH HHS RF1 AG072053NIA NIH HHS RF1 AG073979NIA NIH HHS U01 AG010483NIA NIH HHS U24 AG057437NIGMS NIH HHS T32 GM007198
6 · The paper itself

Abstract

As the CNS-resident macrophages and member of the myeloid lineage, microglia fulfill manifold functions important for brain development and homeostasis. In the context of neurodegenerative diseases, they have been implicated in degenerative and regenerative processes. The discovery of distinct activation patterns, including increased phagocytosis, indicated a damaging role of myeloid cells in multiple system atrophy (MSA), a devastating, rapidly progressing atypical parkinsonian disorder. Here, we analyzed the gene expression profile of microglia in a mouse model of MSA (

Indexed as

Multiple System AtrophyAnimalsDisease Models, AnimalLongevityMiceMicrogliaMyeloid CellsOrganic ChemicalsReceptors, Colony-Stimulating FactorReceptors, Granulocyte-Macrophage Colony-Stimulating FactorCsf1r protein, mouseOrganic ChemicalsPLX5622Receptors, Colony-Stimulating FactorReceptors, Granulocyte-Macrophage Colony-Stimulating Factorcolony-stimulating factor 1 receptormotor functionmultiple system atrophymyeloid cellsneuron–microglia interactionPLX5622

Identifiers

PMID36333098
PMCPMC9546481
OpenAlexW4294795572

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.